Abstract | DOI: https://doi.org/10.31579/2834-796X/075
Echocardiographic abnormalities in chronic hemodialysis patients
*Corresponding Author: Meriam Amri, CHU Ibn Rochd, Cardiology department, Casablanca, Morocco.
Citation: M. Amri, Z. Amine, B. Abdalani, R. Habbal, (2024), Echocardiographic abnormalities in chronic hemodialysis patients, International Journal of Cardiovascular Medicine, 3(5); DOI:10.31579/2834-796X/075
Copyright: © 2024, Meriam Amri. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 12 September 2024 | Accepted: 24 September 2024 | Published: 11 October 2024
Keywords: .
Abstract
Introduction: Cardiovascular abnormalities are prevalent and often insidious in individuals with renal insufficiency, significantly contributing to mortality and morbidity among hemodialysis patients. Echocardiography plays a crucial role in detecting these abnormalities early, allowing for tailored interventions. This study aimed to assess the prevalence of echocardiographic findings in chronic hemodialysis patients.
Methods: This descriptive study was conducted at the cardiology department of Ibn Rochd University Hospital from July 2022 to December 2023. Forty-two chronic hemodialysis patients were included, selected from ambulatory echocardiography consultations or cardiac hospitalizations. Transthoracic echocardiography examinations were performed.
Results: Forty-two participants (25 women, 17 men) with an average age of 45.34 ± 13.4 years were enrolled. Left ventricular hypertrophy (LVH) was the most common abnormality, affecting 54.7% of the cohort. Valvulopathy was identified in 41% of cases, with 10% showing valve calcifications. Left ventricular dilatation was present in 29.8% of participants. Pulmonary arterial hypertension was detected in 9% of cases, and pericarditis in 3.2%. The mean systolic ejection fraction (EF) was 51.52 ± 6.02%, with 10.4% displaying systolic dysfunction of the left ventricle.
Discussion: Our findings corroborate global research, underscoring LVH as the predominant anomaly. Echocardiography emerges as indispensable in identifying these abnormalities, guiding tailored interventions to mitigate cardiovascular risk in hemodialysis patients.
Conclusion: Echocardiography proves invaluable in diagnosing cardiac anomalies non-invasively, offering precision and reproducibility. Given the high prevalence of cardiac-related mortality in hemodialysis patients, its integration into clinical management protocols is imperative for improved patient outcomes.